# A Study of MG1111 in Healthy Children

> **NCT03375502** · PHASE2,PHASE3 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 814 (actual)

## Conditions studied

- Healthy Children

## Interventions

- **DRUG:** Varicella Vaccine

## Key facts

- **NCT ID:** NCT03375502
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-26
- **Primary completion:** 2019-01-29
- **Final completion:** 2019-07-31
- **Target enrollment:** 814 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375502, "A Study of MG1111 in Healthy Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03375502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*